HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stem-cell skin care?

This article was originally published in The Rose Sheet

Executive Summary

National Stem Cell Holding has announced that it will file a provisional patent application for a group of biomaterials that could be suitable for use in anti-aging skin-care products. Derived from the firm's stem cell and progenitor cell lines, the biomaterials "may stimulate a variety of naturally occurring physiological mechanisms that are involved with the skin's ability to preserve and repair itself," the firm says in Oct. 16 release. "These newly discovered biomaterials appear to promote the skin's natural ability to maintain youthful tone, texture and viscoelasticity," it adds. The company notes that further research needs to be conducted, but that the biomaterials may be incorporated eventually in cosmeceuticals, cosmetics and post-surgery applications, providing access to what is expected to be a $70 mil. market for anti-aging solutions within three years, according to National Stem Cell Holding...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel